News 30 Apr 2026 [2026 First Half Innovative Patent Technology Awards] Developing Gene Therapies Using AI Glugene Therapeutics (CEO Moon-soo Lee) is expanding its business based on its precision gene delivery (AAV) development technology. The company… GluGene
